TipRanks
Alamar Biosciences, Inc. (ALMR)
NASDAQ:ALMR
US Market

Alamar Biosciences, Inc. (ALMR) Income Statement

22 Followers

Alamar Biosciences, Inc. Income Statement

Last quarter (Q2 2026), Alamar Biosciences, Inc.'s total revenue was $29.43M, an increase of 13.03% from previous quarter. In Q2, Alamar Biosciences, Inc.'s net income was $-13.20M. See Alamar Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25
Total Revenue
$ 74.21M
Gross Profit
$ 41.70M
Operating Expenses
$ 73.04M
Depreciation and Amortization
$ 3.86M
EBITDA
$ -24.89M
Operating Income
$ -31.33M
Other Income/Expenses
$ 2.18M
Pretax Income
$ -29.15M
Net Income
$ -29.82M
Per Share Metrics
Basic EPS
$ -0.45
Diluted EPS
$ -0.45
Weighted Average Shares Outstanding
66.52M
Weighted Average Shares Outstanding (Diluted)
66.52M
Currency in USD

Alamar Biosciences, Inc. Earnings and Revenue History